已核实 DOI PubMed 相关产品: 8

Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for “on-demand” drug delivery

Journal 2019 · IF 7.901 · 发表于 2019 年 1 月 19 日
作者: Ying Qu,Bingyang Chu,Xiawei Wei,Minyi Lei,Danrong Hu,Ruoyu Zha,Lin Zhong,Mengyao Wang,Fangfang Wang,Zhiyong Qian
阅读全文 在 PubMed 查看

摘要

At present, chemotherapy remains to be one of the most important therapeutic approaches for malignant tumors. The tumor microenvironment(TME)-responsive intelligent drug delivery systems are still the hot research topics in delivering chemotherapeutic drugs. Camptothecin (CPT) possesses very strong antitumor activities , but its clinical application is hindered by its poor water-solubility and serious toxic side effects. Herein, a new intelligent and TME-responsive P(CPT-MAA) prodrug nanogel was developed for delivering CPT and reducing its side effects. P(CPT-MAA) prodrug nanogels were prepared with methacrylic acid (MAA), CPT monomer (CPTM) and N , N ′-methylenebisacrylamide (Bis) via distillation-precipitation polymerization, in which CPT was covalently conjugated into the nanogels via redox-responsive disulfide linker. The as-prepared nanogels were spherical shapes with uniform size and narrow size distribution. With the help of redox-responsive property of disulfide linker and pH-responsive property of PMAA, the release of CPT from prodrug nanogels was redox/pH-dual dependent and could be accelerated by the increased concentration of GSH and the decreased pH value, which were favorable to realize the “on-demand” drug release in tumor cell and tumor tissue microenvironment. Furthermore, P(CPT-MAA) prodrug nanogels exhibited superior antitumor activity both in vitro and in vivo without observed side effects. Hence, the prepared P(CPT-MAA) prodrug nanogels may be a promise delivery system for chemotherapeutic agents.

本研究中使用的阿拉丁产品

8 款产品在本文中被引用